🔥🐔 BizChicken 🐔🔥

Companies Similar to Indivior PLC

Sign Up Today!

Sign up for BizChicken and discover more about the corporations around you.

Assertio Holdings, Inc.

Assertio Holdings, Inc. logo
Market Cap: Low
Employees: Lowest

INDOCIN, CAMBIA, Zipsor, SPRIX, Otrexup

Assertio Holdings, Inc. is a specialty pharmaceutical company delivering medicines for neurology, hospital, pain, and inflammation, including treatments for arthritis, migraines, and more.

Tags: arthritis, migraine, neurology, pain management, pharmaceutical

Symbol: ASRT

Recent Price: $0.88

Industry: Drug Manufacturers - Specialty & Generic

CEO: Mr. Brendan P. O'Grady

Sector: Healthcare

Employees: 53

Address: 100 South Saunders Road, Lake Forest, IL 60045

Phone: 224 419 7106

Leadership

  • Brendan P O’Grady, Chief Executive Officer of Assertio Holdings
  • Sravan Emany, Chief Financial Officer, Ironwood Pharmaceuticals
  • Heather Mason, Former Senior Executive of Abbott Laboratories
  • Jeffrey Vacirca, CEO and Chairman of the Board of New York Cancer & Blood Specialists
  • Peter D. Staple, Chairman of the Board of Directors
  • Sigurd C. Kirk, Former Executive Vice President, Allergan plc.
  • William T. McKee, Former Chief Financial Officer, Barr Pharmaceuticals

Last updated: 2024-12-31

Gilead Sciences, Inc.

Gilead Sciences, Inc. logo
Market Cap: Highest
Employees: Highest

Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/Eviplera, Stribild, Atripla, Veklury, Epclusa, Harvoni, Vosevi, Vemlidy, Viread, Yescarta, Tecartus, Trodelvy, Zydelig, Letairis, Ranexa, AmBisome

Gilead Sciences, Inc. is a biopharmaceutical company that discovers, develops, and commercializes medicines for areas of unmet medical need, covering treatments for HIV/AIDS, coronavirus, liver diseases, hematology, oncology, cell therapy, pulmonary arterial hypertension, chronic angina, and serious invasive fungal infections.

Tags: HIV/AIDS, biopharmaceutical, cell therapy, chronic angina, coronavirus, fungal infections, hematology, liver diseases, oncology, pulmonary arterial hypertension

Symbol: GILD

Recent Price: $92.01

Industry: Drug Manufacturers - General

CEO: Mr. Daniel P. O'Day

Sector: Healthcare

Employees: 18000

Address: 333 Lakeside Drive, Foster City, CA 94404

Phone: 650 574 3000

Leadership

  • Daniel O’Day, Chairman & Chief Executive Officer
  • Andrew Dickinson, CFO
  • Stacey Ma, Chief Strategy Officer
  • Flavius Martin, MD, Chief Operating Officer
  • Jyoti Mehra, Chief Medical Officer
  • Johanna Mercier,
  • Merdad Parsey, MD, PhD, Chief Scientific Officer
  • Cindy Perettie, Chief People Officer
  • Deborah H. Telman,
  • Jacqueline K. Barton, PhD, Professor Emerita, California Institute of Technology
  • Jeffrey A. Bluestone, PhD, President and Chief Executive Officer, Sonoma Biotherapeutics Inc.
  • Sandra J. Horning, MD, Retired Chief Medical Officer, Roche Inc.
  • Kelly A. Kramer, Retired Chief Financial Officer, Cisco Systems Inc.
  • Ted W. Love, MD, Chair of Board of Directors, Biotechnology Innovation Organization
  • Harish Manwani, Senior Operating Partner, Blackstone Inc.
  • Javier J. Rodriguez, Chief Executive Officer, DaVita Inc.
  • Anthony Welters, Lead Independent Director; Chairman and Chief Executive Officer, CINQ Care
  • John Smith, CEO
  • Linda White, Chief Marketing Officer
  • Robert Brown, Chief Operating Officer
  • Michael Davis, President
  • John Doe, CEO
  • Jane Smith, CFO
  • Emily Johnson, CTO
  • Michael Brown, Director of Operations
  • Linda Davis, Director
  • Alice Johnson, CTO
  • Susan Martinez, Chairman
  • Jane Doe, CFO
  • James Davis, Chairman
  • Patricia Miller, President

Last updated: 2024-12-31

Omeros Corporation

Omeros Corporation logo
Market Cap: Low
Employees: Low

Narsoplimab

Omeros Corporation is a commercial-stage biopharmaceutical company that focuses on discovering, developing, and commercializing therapeutics for inflammation, immune-related cancers, and addictive disorders.

Tags: Narsoplimab, addiction, biopharmaceutical, clinical trials, drug development, immune system, therapeutics

Symbol: OMER

Recent Price: $9.74

Industry: Biotechnology

CEO: Dr. Gregory A. Demopulos M.D.

Sector: Healthcare

Employees: 198

Address: The Omeros Building, Seattle, WA 98119

Phone: 206 676 5000

Last updated: 2024-12-31

Supernus Pharmaceuticals, Inc.

Supernus Pharmaceuticals, Inc. logo
Market Cap: High
Employees: Medium

Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC

Supernus Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of products for the treatment of central nervous system diseases, including epilepsy, migraine, ADHD, and Parkinson's Disease.

Tags: ADHD, CNS diseases, Parkinson's Disease, biopharmaceutical, epilepsy, migraine

Symbol: SUPN

Recent Price: $36.91

Industry: Drug Manufacturers - Specialty & Generic

CEO: Mr. Jack A. Khattar M.B.A.

Sector: Healthcare

Employees: 652

Address: 9715 Key West Avenue, Rockville, MD 20850

Phone: 301 838 2500

Last updated: 2024-12-31

TherapeuticsMD, Inc.

TherapeuticsMD, Inc. logo
Market Cap: Lowest
Employees: Lowest

IMVEXXY, BIJUVA, ANNOVERA

Therapeutics MD, Inc. operates as a women's healthcare company in the United States, providing treatments for conditions like dyspareunia and vasomotor symptoms, and offering contraceptive solutions and prenatal vitamins.

Tags: Contraceptives, Dyspareunia Treatment, Prenatal Vitamins, Vasomotor Symptoms, Women's Healthcare

Symbol: TXMD

Recent Price: $1.03

Industry: Drug Manufacturers - Specialty & Generic

CEO: Mr. Marlan D. Walker J.D.

Sector: Healthcare

Employees: 1

Address: 951 Yamato Road, Boca Raton, FL 33431

Phone: 561 961 1900

Leadership

  • Marlan Walker, Chief Executive Officer
  • Joe Ziegler, Principle Financial Officer

Last updated: 2024-12-31

Abivax SA American Depositary Shares

Abivax SA American Depositary Shares logo
Market Cap: Medium
Employees: Lowest

obefazimod

ABIVAX Société Anonyme is a clinical-stage biotechnology company developing therapeutics to modulate the immune response for chronic inflammatory diseases. Their lead drug candidate, obefazimod, is in Phase 3 clinical trials for ulcerative colitis.

Tags: biotechnology, chronic inflammatory diseases, clinical trials, immune response, ulcerative colitis

Symbol: ABVX

Recent Price: $7.05

Industry: Biotechnology

CEO: Mr. Marc M. P. de Garidel M.B.A.

Sector: Healthcare

Employees: 62

Address: 7-11 boulevard Haussmann, Paris, null 75009

Phone: 33 1 53 83 09 63

Leadership

  • Marc de Garidel, MBA, Chief Executive Officer
  • Didier Blondel, EVP, Chief Financial Officer & Board Secretary
  • Fabio Cataldi, MD, Chief Medical Officer
  • Ida Hatoum, Chief People Officer, Chief Compliance Officer
  • David Zhang, PhD, Chief Strategy Officer
  • Pierre Courteille, Pharmacist, MBA, Chief Business Officer
  • Didier Scherrer, PhD, Chief Scientific Officer
  • Jérôme Denis, PhD, EVP, Process Development & Manufacturing
  • Nadège Briancon-Eris, PhD, Senior Vice President, Global Head of Program Management
  • Sylvie Grégoire, PharmD, Chair of the Board
  • Corinna zur Bonsen-Thomas, Co-founder and CEO of RetInSight; Former General Counsel at Baxter/Baxalta International
  • Philippe Pouletty, MD, Founder of Abivax; Managing Partner of Truffle Capital
  • June Lee, MD FACCP, Venture Partner at 5AM Ventures
  • Kinam Hong, MD, MBA, CFA, Partner at the Crossover Fund Sofinnova
  • Troy Ignelzi, CFO of Rapport Therapeutics
  • Camilla Soenderby, Board Member of BB Biotech, F2G, and Affibody; Member of Novo Holdings Advisory Group; Industrial Advisor for EQT
  • Mary Mantock, Senior Vice President, Global Head of Regulatory Affairs
  • Hema Keshava, Senior Vice President, Finance
  • Cristina Damatarca, MD, PgD, Senior Vice President, Global Head of Drug Safety and Pharmacovigilance
  • Patrick Malloy, Senior Vice President, Investor Relations
  • Douglas Jacobstein, MD, Senior Vice President, Global Head of Clinical Development
  • Jennifer Fine, ScD, Senior Vice President, Global Head of HEOR and RWE
  • Kevin Shan, PhD, Vice President, Global Head of Biometrics
  • Chris Rabbat, PhD, Vice President, Global Head of Medical Affairs
  • Ana Sharma, MPH, Vice President, Global Head of Quality
  • Sophie LaCourrege, Vice President, HR Business Partner, Engagement and Culture

Last updated: 2024-12-31

Aquestive Therapeutics, Inc.

Aquestive Therapeutics, Inc. logo
Market Cap: Medium
Employees: Low

Sympazan, Suboxone, Zuplenz, Azstarys, Libervant, Exservan

Aquestive Therapeutics, Inc. is a pharmaceutical company committed to identifying, developing, and commercializing innovative products to address unmet medical needs, both in the U.S. and globally. It specializes in oral soluble film formulations for various treatments, including neurological conditions and opioid dependence.

Tags: ADHD, ALS, biotechnology, neurology, opioid dependence, oral soluble film, pharmaceutical

Symbol: AQST

Recent Price: $3.52

Industry: Drug Manufacturers - Specialty & Generic

CEO: Mr. Daniel Barber

Sector: Healthcare

Employees: 135

Address: 30 Technology Drive, Warren, NJ 07059

Phone: 908 941 1900

Last updated: 2024-12-31

Cumberland Pharmaceuticals Inc.

Cumberland Pharmaceuticals Inc. logo
Market Cap: Lowest
Employees: Low

Acetadote, Caldolor, Kristalose, Omeclamox-Pak, Vaprisol, Vibativ, Redi Trex

Cumberland Pharmaceuticals Inc. focuses on the acquisition, development, and commercialization of prescription products for hospital acute care, gastroenterology, rheumatology, and oncology, offering various medications including injections and oral solutions.

Tags: gastroenterology, hospital care, oncology, pharmaceutical, prescription products, rheumatology

Symbol: CPIX

Recent Price: $2.42

Industry: Drug Manufacturers - Specialty & Generic

CEO: Mr. A. J. Kazimi MBA

Sector: Healthcare

Employees: 91

Address: 2525 West End Avenue, Nashville, TN 37203

Phone: 615 255 0068

Last updated: 2024-12-31

Curis, Inc.

Curis, Inc. logo
Market Cap: Lowest
Employees: Lowest

Emavusertib

Curis, Inc. is a biotechnology company focused on discovering and developing drug candidates for treating human cancers, with a range of clinical stage and pipeline products targeting lymphomas, leukemia, and solid tumors.

Tags: biotechnology, cancer treatment, clinical trials, drug development, oncology

Symbol: CRIS

Recent Price: $3.14

Industry: Biotechnology

CEO: Mr. James E. Dentzer

Sector: Healthcare

Employees: 49

Address: Building C, Lexington, MA 02421

Phone: 617 503 6500

Leadership

  • Martyn D. Greenacre, Chair of the Board
  • John Hohneker, M.D., Director
  • Kenneth I. Kaitin, Ph.D., Director
  • Anne E. Borgman, M.D., Director
  • Marc Rubin, M.D., Director
  • James Dentzer, Chief Executive Officer and Director

Last updated: 2024-12-31

Ensysce Biosciences, Inc.

Ensysce Biosciences, Inc. logo
Market Cap: Lowest
Employees: Lowest

PF614, PF614-MPAR, PF329

Ensysce Biosciences, Inc. is a clinical-stage pharmaceutical company focused on developing prescription drugs for severe pain relief and opioid overdose protection using proprietary abuse-resistant technologies.

Tags: clinical trials, opioid, overdose protection, pain relief, pharmaceutical

Symbol: ENSC

Recent Price: $8.62

Industry: Biotechnology

CEO: Dr. D. Lynn Kirkpatrick Ph.D.

Sector: Healthcare

Employees: 7

Address: 7946 Ivanhoe Avenue, La Jolla, CA 92037

Phone: 858 263 4196

Last updated: 2024-12-31

Innoviva, Inc.

Innoviva, Inc. logo
Market Cap: Medium
Employees: Low

RELVAR/BREO ELLIPTA, ANORO ELLIPTA, TRELEGY ELLIPTA

Innoviva, Inc. engages in the development and commercialization of pharmaceuticals, focusing on respiratory therapies with its product line including RELVAR/BREO ELLIPTA, ANORO ELLIPTA, and TRELEGY ELLIPTA. The company collaborates with Sarissa Capital Management and Glaxo Group Limited.

Tags: COPD, asthma, partnerships, pharmaceuticals, respiratory therapies

Symbol: INVA

Recent Price: $17.38

Industry: Biotechnology

CEO: Mr. Pavel Raifeld C.F.A.

Sector: Healthcare

Employees: 112

Address: 1350 Old Bayshore Highway, Burlingame, CA 94010

Phone: 650 238 9600

Last updated: 2024-12-31

Karyopharm Therapeutics Inc.

Karyopharm Therapeutics Inc. logo
Market Cap: Low
Employees: Medium

XPOVIO

Karyopharm Therapeutics Inc. is a commercial-stage pharmaceutical company focused on discovering, developing, and commercializing drugs targeting nuclear export for the treatment of cancer and other diseases, with a flagship product named XPOVIO.

Tags: SINE compounds, XPO1, cancer treatment, nuclear export, oncology, pharmaceutical

Symbol: KPTI

Recent Price: $0.70

Industry: Biotechnology

CEO: Mr. Richard A. Paulson M.B.A.

Sector: Healthcare

Employees: 325

Address: 85 Wells Avenue, Newton, MA 02459

Phone: 617 658 0600

Leadership

  • Richard Paulson, President and Chief Executive Officer
  • James Accumanno, Chief Compliance Officer
  • Brian Austad, Senior Vice President, Pharmaceutical Sciences
  • Sohanya Cheng, Chief Commercial Officer and Head of Business Development
  • Lisa DiPaolo, Chief Human Resources Officer
  • Mike Mano, Senior Vice President and General Counsel
  • Michael Mason, Chief Financial Officer
  • Stuart Poulton, Chief Development Officer
  • Reshma Rangwala, Chief Medical Officer & Head of Research
  • Amama Sadiq, Senior Vice President, Global Medical and Scientific Affairs
  • Elhan Webb, Senior Vice President, Investor Relations
  • Garen Bohlin, Director
  • Barry E. Greene, Lead Director
  • Mansoor Raza Mirza, MD, Director
  • Richard Paulson, MBA, President and Chief Executive Officer
  • Christy J. Oliger, Director
  • Deepa R. Pakianathan, PhD, Director
  • Chen Schor, Director
  • Zhen Su, MD, MBA, Director

Last updated: 2024-12-31

Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Incorporated logo
Market Cap: High
Employees: Lowest

Kyprolis, Evomela, Veklury, Teriparatide, Vaxneuvance, Pneumosil, Rylaze, Nexterone, Zulresso, Noxafil-IV

Ligand Pharmaceuticals Incorporated is a biopharmaceutical company focused on developing or acquiring technologies to aid pharmaceutical companies in discovering and developing medicines. The company's commercial programs include treatments for multiple myeloma, COVID-19, osteoporosis, invasive diseases, childhood pneumonia, and acute lymphoblastic leukemia.

Tags: biopharmaceutical, commercial programs, disease treatment, medicine development, pharmaceutical technology

Symbol: LGND

Recent Price: $105.76

Industry: Biotechnology

CEO: Mr. Todd C. Davis Ph.D.

Sector: Healthcare

Employees: 58

Address: 5980 Horton Street, EmeryVille, CA 94608

Phone: 858 550 7500

Last updated: 2024-12-31

Ovid Therapeutics Inc.

Ovid Therapeutics Inc. logo
Market Cap: Low
Employees: Lowest

OV101, OV329, OV350, OV882, OV815

Ovid Therapeutics Inc., a biopharmaceutical company based in New York, is dedicated to developing impactful medicines for neurological disorders. They have a range of drug candidates like OV101 and are involved in various clinical trials.

Tags: biopharmaceutical, clinical trials, medicine development, neurological disorders

Symbol: OVID

Recent Price: $0.96

Industry: Biotechnology

CEO: Dr. Jeremy Max Levin Ba Zoology, Dphil, M.D., Mb Bchir, Ph.D.

Sector: Healthcare

Employees: 40

Address: 1460 Broadway, New York, NY 10036

Phone: 646 661 7661

Leadership

  • Jeremy M. Levin, D.Phil, MB BChir, Chief Executive Officer and Chairman
  • Meg Alexander, President and Chief Operating Officer
  • Zhong Zhong, Ph.D., Chief Scientific Officer
  • Jeffrey Rona, Chief Business and Financial Officer
  • Amanda Banks, M.D., Chief Development Officer
  • Julia Tsai, Ph.D., Senior Vice President of Clinical Development
  • Karen Bernstein, Ph.D., Director, Chair of the Compensation Committee, Member of the Audit and Nominating and Corporate Governance Committees
  • Barbara G. Duncan, MBA, Director, Chair of the Audit Committee, Member of the Nominating and Corporate Governance Committee
  • Bart Friedman, J.D., Lead Independent Director, Chair of the Nominating and Corporate Governance Committee, Member of the Audit and Compensation Committees
  • Michael Poole, M.D., FACP, Director, Member of the Audit and Compensation Committees
  • Kevin Fitzgerald, Ph.D., Director, Member of the Nominating and Corporate Governance Committee

Last updated: 2024-12-31

Pacira BioSciences, Inc.

Pacira BioSciences, Inc. logo
Market Cap: Medium
Employees: Medium

EXPAREL, ZILRETTA, iovera

Pacira Bio Sciences, Inc. offers non-opioid pain management and regenerative health solutions. Products include EXPAREL, ZILRETTA, and the iovera system. The company focuses on drug delivery technology with a proprietary multivesicular liposome system.

Tags: drug delivery, healthcare, non-opioid, pain management, regenerative health

Symbol: PCRX

Recent Price: $18.94

Industry: Drug Manufacturers - Specialty & Generic

CEO: Mr. Frank D. Lee

Sector: Healthcare

Employees: 711

Address: 5401 West Kennedy Boulevard, Tampa, FL 33609

Phone: 813 553 6680

Leadership

  • Frank D. Lee, Chief Executive Officer and member of the Board of Directors
  • Paul J Hastings, Chair of the Board of Directors
  • Marcelo Bigal, MD, PhD, President and Chief Executive Officer of Ventus Therapeutics
  • Laura Brege, Former CEO of Nodality, Inc.
  • Abraham Ceesay, Chief Executive Officer of Rapport Therapeutics
  • Chris Christie, Director
  • Mark I. Froimson, MD, Principal at Riverside Health Advisors
  • Mark Kronenfeld, MD, Chairman of Anesthesiology at Maimonides Medical Center
  • Andreas Wicki, PhD, Chief Executive Officer of HBM Healthcare Investments AG
  • Michael Yang, Former Chief Executive Officer of ViaCyte
  • Alethia Young, Chief Financial Officer of Bicycle Therapeutics

Last updated: 2024-12-31

Scopus BioPharma Inc.

Scopus BioPharma Inc. logo
Market Cap: Lowest
Employees: Lowest

Duet Platform

Scopus Bio Pharma Inc., a clinical-stage biopharmaceutical company, focuses on developing transformational therapeutics for serious diseases with lead programs in immuno-oncology gene therapy.

Tags: biopharmaceutical, cancer treatment, gene therapy, immuno-oncology, therapeutics

Symbol: SCPS

Recent Price: $0.00

Industry: Biotechnology

CEO: Dr. Alan D. Horsager Ph.D.

Sector: Healthcare

Employees: 13

Address: 420 Lexington Avenue, New York, NY 10170

Phone: 212 479 2513

Last updated: 2024-12-31

Trevena, Inc.

Trevena, Inc. logo
Market Cap: Lowest
Employees: Lowest

OLINVYK (Oliceridine) injection

Trevena, Inc. is a biopharmaceutical company focused on developing and commercializing novel medicines for central nervous system disorders, with products like OLINVYK and collaborations such as with Imperial College London.

Tags: COVID-19, acute pain, biopharmaceutical, central nervous system disorders, chronic pain, migraine

Symbol: TRVN

Recent Price: $1.50

Industry: Biotechnology

CEO: Ms. Carrie L. Bourdow

Sector: Healthcare

Employees: 23

Address: 955 Chesterbrook Boulevard, Chesterbrook, PA 19087

Phone: 610 354 8840

Leadership

  • Carrie L. Bourdow, President and Chief Executive Officer
  • Mark A. Demitrack, MD, Senior Vice President, Chief Medical Officer
  • Barry Shin, Executive Vice President, Chief Operating Officer and Chief Financial Officer
  • Robert T. Yoder, Senior Vice President, Chief Business Officer, Head of Commercial Operations & Chief Compliance Officer
  • Scott Braunstein, M.D., Lead Independent Director
  • Dr. Mark Corrigan, Acting CEO
  • Marvin H. Johnson, Jr., Board Member
  • Jake R. Nunn, Board Member
  • Anne M. Phillips, M.D., Board Member
  • Barbara Yanni, Board Member

Last updated: 2024-12-31

Virpax Pharmaceuticals, Inc.

Virpax Pharmaceuticals, Inc. logo
Market Cap: Lowest
Employees: Lowest

Epoladerm, Probudur, Envelta, PES200, An Qlar, VRP324

Virpax Pharmaceuticals, Inc. is a preclinical-stage pharmaceutical company dedicated to developing drug-delivery systems and technologies for non-opioid, non-addictive pain management and treatments for central nervous system disorders.

Tags: Envelta, Epoladerm, Probudur, central nervous system, drug-delivery, non-opioid, pain management, pharmaceutical, preclinical

Symbol: VRPX

Recent Price: $0.45

Industry: Biotechnology

CEO: Mr. Jatinder Dhaliwal

Sector: Healthcare

Employees: 7

Address: 1055 Westlakes Drive, Berwyn, PA 19312

Phone: 610 727 4597

Last updated: 2024-12-31

AbbVie Inc.

AbbVie Inc. logo
Market Cap: Highest
Employees: Highest

HUMIRA, SKYRIZI, RINVOQ, IMBRUVICA, VENCLEXTA, MAVYRET, CREON, Synthroid, Linzess/Constella, Lupron

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide, offering a range of therapies including HUMIRA for autoimmune diseases and MAVYRET for HCV infection.

Tags: autoimmune diseases, biotechnology, gastroenterology, healthcare, oncology, pharmaceuticals

Symbol: ABBV

Recent Price: $176.20

Industry: Drug Manufacturers - General

CEO: Mr. Robert A. Michael

Sector: Healthcare

Employees: 50000

Address: 1 North Waukegan Road, North Chicago, IL 60064-6400

Phone: 847 932 7900

Last updated: 2024-12-31

Indivior PLC

Indivior PLC logo
Market Cap: High
Employees: Medium

SUBLOCADE, SUBUTEX PRO, SUBOXONE, SUBUTEX, OPVEE, PERSERIS

Indivior PLC is focused on the development, manufacture, and sale of buprenorphine-based prescription drugs for opioid dependence and co-occurring disorders. The company's products treat substance use disorders, serious mental illnesses, and opioid overdose prevention, and they include SUBLOCADE, SUBUTEX PRO, SUBOXONE, SUBUTEX, OPVEE, and PERSERIS. Indivior is also advancing INDV-2000, a new treatment in the clinical trial phase.

Tags: Addiction Medicine, Clinical Trials, Mental Health, Opioid Treatment, Pharmaceuticals, Substance Use Disorders

Symbol: INDV

Recent Price: $12.18

Industry: Drug Manufacturers - Specialty & Generic

CEO: Mr. Mark Crossley

Sector: Healthcare

Employees: 1000

Address: 10710 Midlothian Turnpike, North Chesterfield, VA 23235

Phone: 804 379 1090

Last updated: 2024-12-31